Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	1,033	1,751	1,295	3,298	2,064
Trading Asset Securities	-	5,599	4,387	3,301	5,103	1,219
Cash & Short-Term Investments	6,631	6,631	6,138	4,595	8,401	3,282
Cash Growth	8.03%	8.03%	33.58%	-45.30%	155.96%	-13.21%
Accounts Receivable	-	18,539	11,827	12,468	10,569	10,198
Other Receivables	-	1,454	412	696.6	459.2	460.5
Receivables	-	20,010	12,265	13,505	11,202	10,722
Inventory	-	9,385	9,039	8,284	8,156	7,911
Prepaid Expenses	-	325.5	245.8	259.2	164.4	155.8
Other Current Assets	-	1,002	742.9	666.4	416.2	573.6
Total Current Assets	-	37,354	28,430	27,309	28,340	22,645
Property, Plant & Equipment	-	20,834	18,918	17,210	16,982	16,474
Long-Term Investments	-	285	252.4	227.4	290	294.2
Other Intangible Assets	-	415.8	465.2	146.6	77.5	90.2
Long-Term Deferred Tax Assets	-	1,886	1,864	1,345	967.7	555.5
Other Long-Term Assets	-	773.2	219.6	146.4	133.4	497.1
Total Assets	-	61,548	50,150	46,384	46,790	40,556

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	5,443	4,542	4,632	4,228	3,272
Accrued Expenses	-	3,749	3,354	671.3	356.8	375.9
Short-Term Debt	-	57.4	35	30.5	38.4	94.9
Current Portion of Leases	-	2,208	127	102.7	94.3	64.6
Current Income Taxes Payable	-	54.9	405.3	447.7	330.7	79.4
Current Unearned Revenue	-	-	-	3.3	3.3	3.3
Other Current Liabilities	-	2,645	1,498	3,070	6,342	2,584
Total Current Liabilities	-	14,158	9,961	8,958	11,393	6,474
Long-Term Leases	-	394.2	347.2	235.2	262	185.7
Long-Term Unearned Revenue	-	16.7	20	23.4	26.7	30
Pension & Post-Retirement Benefits	-	83.7	468.6	135	23.2	-
Long-Term Deferred Tax Liabilities	-	1,179	1,105	1,085	977.2	1,019
Other Long-Term Liabilities	-	446	344.6	274.1	228.4	204.1
Total Liabilities	-	16,278	12,247	10,710	12,910	7,912

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	250.7	250.7	251.8	251.8	170.8
Additional Paid-In Capital	-	71.6	36.6	1.8	-	-
Retained Earnings	-	44,496	37,434	35,254	33,523	32,495
Comprehensive Income & Other	-	452.4	181.2	166.2	105	-22.1
Shareholders' Equity	45,271	45,271	37,903	35,674	33,880	32,643
Total Liabilities & Equity	-	61,548	50,150	46,384	46,790	40,556

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	2,659	2,659	509.2	368.4	394.7	345.2
Net Cash (Debt)	3,972	3,972	5,629	4,227	8,006	2,937
Net Cash Growth	-29.44%	-29.44%	33.17%	-47.20%	172.60%	-13.73%
Net Cash Per Share	31.78	31.79	44.97	33.55	62.49	22.65
Filing Date Shares Outstanding	124.94	124.94	125.68	126.68	125.91	128.12
Total Common Shares Outstanding	124.94	124.94	125.68	126.68	125.91	128.12
Working Capital	-	23,197	18,469	18,352	16,947	16,171
Book Value Per Share	362.35	362.35	301.59	281.60	269.07	254.78
Tangible Book Value	44,855	44,855	37,438	35,527	33,802	32,553
Tangible Book Value Per Share	359.03	359.03	297.88	280.44	268.45	254.08
Land	-	1,510	1,467	1,488	1,577	1,575
Buildings	-	8,697	8,113	6,174	6,057	5,870
Machinery	-	18,024	16,364	14,692	13,879	13,276
Construction In Progress	-	2,581	1,763	2,565	2,095	1,529
Leasehold Improvements	-	-	-	-	-	10.9

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error